Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Keytruda

KEYTRUDA 395 mg solution for injection KEYTRUDA 790 mg solution for injection · Abschnitt 4.8 · PDF-Seite 178–179

HOS-131856 · Präparat HOS-097138

178 MedDRA SOC Monotherapy In combination with In combination with and frequency chemotherapy, axitinib or lenvatinib category radiation therapy or chemoradiotherapy Common colitis⁎, dry mouth colitis⁎, gastritis⁎, dry colitis⁎, pancreatitis⁎, mouth gastritis⁎, dry mouth Uncommon pancreatitis⁎, pancreatitis⁎, gastrointestinal gastritis⁎, gastrointestinal ulceration⁎ gastrointestinal ulceration⁎ ulceration⁎ Rare pancreatic exocrine pancreatic exocrine small intestinal insufficiency, small insufficiency, small perforation intestinal intestinal perforation, perforation, coeliac coeliac disease disease Not known pancreatic exocrine insufficiency, coeliac disease Hepatobiliary disorders Common hepatitis⁎ hepatitis⁎ hepatitis⁎ Rare cholangitis cholangitis sclerosing⁎ sclerosing Skin and subcutaneous tissue disorders Very common pruritus⁎, rash⁎ alopecia, pruritus⁎, rash⁎ rash⁎, pruritus⁎

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.